Cathie Wood的ARK ETFS利用Coinbase（Coin）和Robinhood（Hood）Stocks的回调

Cathie Wood的ARK ETF资本以Coinbase（Coin）和Robinhood（Hood）股票的回调资源为加载额外的股票

Cathie Wood’s ARK ETFs capitalized on the pullback in Coinbase (NASDAQ:COIN) and Robinhood (NASDAQ:HOOD) stocks to load up additional shares on Thursday. The trades come as some of Cathie’s picks are beginning to look like bargain buys with the recent market downturn and uncertainty making some U.S. stocks hit attractive price levels.

凯茜·伍德（Cathie Wood）的方舟ETF资本利用了Coinbase（NASDAQ：COIN）和Robinhood（Nasdaq：Hood）股票的回调，并在周四加载了额外的股票。交易是因为Cathie的某些选秀开始看起来像是在最近的市场经济下滑和不确定性的情况下购买的便宜货，使一些美国股票达到了吸引人的价格水平。

The ARK Innovation Fund (ARKK) purchased 29,353 shares of Coinbase for $5.63 million following the recent sell-off in COIN stock. The new grant of shares comes after the S&P 500 (SPX) Index decided against including Coinbase in the index and the crypto markets crashed to lower highs. The transactions highlight Cathie Wood’s persistent interest in disruptive technologies like cryptocurrency. Earlier this week, the ARKK ETF acquired 52,573 shares of the crypto platform, while the ARK Fintech Innovation ETF (ARKF) bought 11,605 shares.

在最近抛售硬币股票之后，方舟创新基金（ARKK）以563万美元的价格购买了29,353股Coinbase股票。在标普500（SPX）指数决定不包含Coinbase的指数和加密货币市场崩溃至较低高点之后，新的股票获得了新的股票。交易突出了Cathie Wood对加密货币等破坏性技术的持续兴趣。本周早些时候，ARKK ETF收购了加密平台的52,573股，而ARK Fintech Innovation ETF（ARKF）购买了11,605股。

Another notable trade made yesterday was the purchase of 143,855 shares of Robinhood Markets (NASDAQ:HOOD) at $5.6 million. Earlier this week, the ARKK ETF purchased 269,864 shares of HOOD stock, showcasing Cathie Wood’s confidence in the online brokerage platform.

昨天进行的另一个值得注意的贸易是购买了143,855股Robinhood Markets（NASDAQ：HOOD），价格为560万美元。本周早些时候，ARKK ETF购买了269,864股Hood Stock，展示了Cathie Wood对在线经纪平台的信心。

The ARKK ETF and the ARK Genomic Revolution ETF (ARKG) also bought a total of 105,974 CRISPR Therapeutics (NASDAQ:CRSP) shares for $4.6 million and 80,975 GitLab (NASDAQ:GTLB) shares for $4.27 million.

ARKK ETF和ARK基因组革命ETF（ARKG）还以460万美元的股份和80,975 Gitlab（NASDAQ：GTLB）股票总共购买了105,974 CRISPR Therapeutics（NASDAQ：CRSP）股票，以4.27亿美元的价格购买了。

Using TipRanks’ Stock Comparison Tool, let’s see what Wall Street’s rating on Cathie’s stock picks are.

使用Tipranks的股票比较工具，让我们看看华尔街对Cathie股票选秀权的评分是什么。

Wall Street has a Strong Buy consensus rating on GitLab stock. Analysts see a 57.4% upside potential in the stock of the cloud-based software development tools provider.

华尔街对Gitlab股票的共识评级很高。分析师认为基于云的软件开发工具提供商的股票中有57.4％的上升潜力。

Cathie’s ARK ETFs also dumped a large sum of UiPath (NYSE:PATH) stock on Thursday with the ARKK ETF and the ARK Next Generation Internet ETF (ARKW) selling a collective 1,101,216 shares of PATH stock for $13 million. The move comes after the automation software company reported mixed Q4 results and soft guidance.

Cathie的ARK ETF还在周四与ARKK ETF和ARKK Next Generation Internet ETF（ARKW）一起倾倒了大量的Uipath（NYSE：PATH）股票，以1,101,216股的股票售价为1300万美元。此举是在自动化软件公司报告了第二季度结果和软指导之后。

The reduced exposure to UiPath follows the recently reported mixed Q4 results and soft guidance, which may have led Cathie to decrease their holdings.

在最近报道的Q4结果和软指导下，对Uipath的接触减少了，这可能导致Cathie减少了其持有量。

With macro pressures continuing to weigh on the economy and markets, it seems that analysts are keeping a close eye on how the increased pressures from inflation and the looming threat of a recession will affect demand for UiPath’s products. This caution is reflected in the Hold consensus rating on PATH stock based on three Buys, 15 Holds, and two Sell recommendations. The average PATH stock price target of $12.06 implies about 21% upside potential.

随着宏观压力继续压力经济和市场，分析师似乎一直在密切关注通货膨胀和衰退的迫在眉睫的威胁如何影响对Uipath产品的需求。该谨慎反映在基于三个购买，15个持有和两个卖出建议的路径库存的持有共识评级中。 12.06美元的平均股票价格目标意味着大约21％的上行潜力。